Eradication and phenotypic tolerance of Burkholderia cenocepacia biofilms exposed to atmospheric pressure non-thermal plasma

International Journal of Antimicrobial Agents

Volumn 47, Issue 6, 2016, Pages 446-450

  Alshraiedeh, Nida H ^a,b   Higginbotham, Sarah ^a   Flynn, Padrig B ^a   Alkawareek, Mahmoud Y ^c   Tunney, Michael M ^a   Gorman, Sean P ^a   Graham, William G ^a   Gilmore, Brendan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^c UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Biofilm; Burkholderia cenocepacia; Catalase; Non thermal plasma; Phenotypic resistance; Tolerance

Indexed keywords

DISINFECTANT AGENT; PLASMA GAS;

ATMOSPHERIC PRESSURE; BIOFILM; BURKHOLDERIA CENOCEPACIA; DRUG EFFECTS; DRUG TOLERANCE; PHARMACOLOGY; PHYSIOLOGY; PLASMA GAS;

ATMOSPHERIC PRESSURE; BIOFILMS; BURKHOLDERIA CENOCEPACIA; DISINFECTANTS; DRUG TOLERANCE; PLASMA GASES;

EID: 84969922961     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2016.03.004     Document Type: Article

References (23)

1. M.H. Akabas Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel J Biol Chem 275 2000 3729 3732
2. National Health Service (NHS) Cystic fibrosis http://www.nhs.uk/conditions/Cystic-fibrosis/Pages/Introduction.aspx 2016 accessed 28.04.16
3. J.A. Dodge, P.A. Lewis, M. Stanton, and J. Wilsher Cystic fibrosis mortality and survival in the UK: 1947-2003 Eur Respir J 29 2007 522 526
4. A.M. Jones, M.E. Dodd, J.R. Govan, V. Barcus, C.J. Doherty, J. Morris, and et al. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis Thorax 59 2004 948 951
5. J.J. LiPuma The changing microbial epidemiology in cystic fibrosis Clin Microbiol Rev 23 2010 299 323
6. E. Mahenthiralingam, P. Vandamme, M.E. Campbell, D.A. Henry, A.M. Gravelle, L.T. Wong, and et al. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans Clin Infect Dis 33 2001 1469 1475
7. P. Drevinek, and E. Mahenthiralingam Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence Clin Microbiol Infect 16 2010 821 830
8. R.M. Donlan Biofilms: microbial life on surfaces Emerg Infect Dis 8 2002 881 890
9. A.S. Messiaen, H. Nelis, and T. Coenye Investigating the role of matrix components in protection of Burkholderia cepacia complex biofilms against tobramycin J Cyst Fibros 13 2014 56 62
10. M.Y. Alkawareek, Q.T. Algwari, S.P. Gorman, W.G. Graham, D. O'Connell, and B.F. Gilmore Application of atmospheric pressure nonthermal plasma for the in vitro eradication of bacterial biofilms FEMS Immunol Med Microbiol 65 2012 381 384
11. M.Y. Alkawareek, Q.T. Algwari, G. Laverty, S.P. Gorman, W.G. Graham, D. O'Connell, and et al. Eradication of Pseudomonas aeruginosa biofilms by atmospheric pressure non-thermal plasma PLoS ONE 7 2012 e44289
12. M.Y. Alkawareek, S.P. Gorman, W.G. Graham, and B.F. Gilmore Potential cellular targets and antibacterial efficacy of atmospheric pressure non-thermal plasma Int J Antimicrob Agents 43 2014 154 160
13. Z. Machala, K. Hensel, and Y. Akishev Plasma for bio-decontamination, medicine and food security 2012 Springer Science & Business Media Dordrecht, The Netherlands
14. N.H. Alshraiedeh, M.Y. Alkawareek, S.P. Gorman, W.G. Graham, and B.F. Gilmore Atmospheric pressure, nonthermal plasma inactivation of MS2 bacteriophage: effect of oxygen concentration on virucidal activity J Appl Microbiol 115 2013 1420 1426
15. H. Ceri, M. Olson, C. Stremick, R. Read, D. Morck, and A. Buret The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms J Clin Microbiol 37 1999 1771 1776
16. S. Stepanović, D. Vuković, I. Dakić, B. Savić, and M. Švabić-Vlahović A modified microtiter-plate test for quantification of staphylococcal biofilm formation J Microbiol Methods 40 2000 175 179
17. M. Laroussi, and F. Leipold Evaluation of the roles of reactive species, heat, and UV radiation in the inactivation of bacterial cells by air plasmas at atmospheric pressure Int J Mass Spectrom 233 2004 81 86
18. Zhang Q., Sun P., Feng H., Wang R., Liang Y., Zhu W., and et al. Assessment of the roles of various inactivation agents in an argon-based direct current atmospheric pressure cold plasma jet J Appl Phys 111 2012 123305
19. A.W. Smith, J. Green, C.E. Eden, and M.L. Watson Nitric oxide-induced potentiation of the killing of Burkholderia cepacia by reactive oxygen species: implications for cystic fibrosis J Med Microbiol 48 1999 419 423
20. R.K. Michl, J. Hentschel, C. Fischer, J.F. Beck, and J.G. Mainz Reduced nasal nitric oxide production in cystic fibrosis patients with elevated systemic inflammation markers PLoS ONE 8 2013 e79141
21. N. Abramzon, J.C. Joaquin, J. Bray, and G. Brelles-Marino Biofilm destruction by RF high-pressure cold plasma jet IEEE Trans Plasma Sci 34 2006 1304 1309
22. Xu L., Tu Y., Yu Y., Tan M., Li J., and Chen H. Augmented survival of Neisseria gonorrhoeae within biofilms: exposure to atmospheric pressure non-thermal plasmas Eur J Clin Microbiol Infect Dis 30 2011 25 31
23. M. Lefebre, and M. Valvano In vitro resistance of Burkholderia cepacia complex isolates to reactive oxygen species in relation to catalase and superoxide dismutase production Microbiology 147 2001 97 109